Oracle ( ORCL 1.63%) is making a bold move, and investors are not exactly pleased with the decision. At least that's the ...
Spun off from a Dividend King in 2013, this pharmaceutical stock is a rising star among dividend growth stocks.
The rise and fall of oil prices are what get the headlines, but that's just the start of the problem the world faces.
Wall Street analysts, who typically don't own the stocks they cover, cater to these funds by providing coverage of stocks ...
On the second trading day of the week, Pfizer ( PFE 2.62%) was a laggard on the stock exchange. An analyst reiterated his ...
Investors juggle foldable iPhone setbacks, softer services growth, and fresh Wall Street optimism on this tech leader, today, ...
One analyst tracking the networking equipment company became notably more bullish on its future.
A crash, economic recession, a liquidity crunch, or another leveraged-liquidation cascade like Oct. 10's could push the price ...
Better Home & Finance Holding ( BETR +11.10%) continues to accumulate financial resources for its core activity, and ...
Join us as we dive into Mastercard's business strengths and weaknesses, revealing why this stock could be a solid investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results